Home > Healthcare > Biguanides Market > Table of Contents

Biguanides Market – By Drug Type (Branded, Generic), Dosage Form (Tablets, Oral Solutions), Formulation (Immediate-release, Extended-release), Distribution Channel (Hospital, Retail, Online Pharmacies), Global Forecast, 2024 – 2032

  • Report ID: GMI8309
  • Published Date: Feb 2024
  • Report Format: PDF

Report Content

Chapter 1   Methodology & Scope

1.1    Market scope & definition

1.2    Base estimates & calculations

1.3    Data collection

1.4    Forecast parameters

1.5    Data validation

1.6    Data sources

1.6.1    Primary

1.6.2    Secondary

1.6.2.1    Paid sources

1.6.2.2    Unpaid sources

Chapter 2   Executive Summary

2.1    Industry 3600 synopsis

Chapter 3   Industry Insights

3.1    Industry ecosystem analysis

3.2    Industry impact forces

3.2.1    Growth drivers

3.2.1.1    Rising prevalence of diabetes

3.2.1.2    High preference for biguanides as first line treatment

3.2.1.3    Advancements in drug delivery technologies

3.2.2    Industry pitfalls & challenges

3.2.2.1    Side effects associated with biguanides

3.3    Growth potential analysis

3.4    Regulatory landscape

3.5    Porter's analysis

3.5.1    Supplier power

3.5.2    Buyer power

3.5.3    Threat of new entrants

3.5.4    Threat of substitutes

3.5.5    Industry rivalry

3.6    PESTEL analysis

Chapter 4   Competitive Landscape, 2023

4.1    Introduction

4.2    Company matrix analysis

4.3    Company market share analysis

4.4    Competitive positioning matrix

4.5    Strategy dashboard

Chapter 5   Market Estimates and Forecast, By Drug Type, 2018 – 2032 ($ Mn)

5.1    Key trends

5.2    Branded

5.3    Generic

Chapter 6   Market Estimates and Forecast, By Dosage Form, 2018 – 2032 ($ Mn)

6.1    Key trends

6.2    Tablets

6.3    Oral solutions

Chapter 7   Market Estimates and Forecast, By Formulation, 2018 – 2032 ($ Mn)

7.1    Key trends

7.2    Immediate-release

7.3    Extended-release

Chapter 8   Market Estimates and Forecast, By Distribution Channel, 2018 – 2032 ($ Mn)

8.1    Key trends

8.2    Hospital pharmacies

8.3    Retail pharmacies

8.4    Online pharmacies

Chapter 9   Market Estimates and Forecast, By Region, 2018 – 2032 ($ Mn)

9.1    Key trends

9.2    North America

9.2.1    U.S.

9.2.2    Canada

9.3    Europe

9.3.1    Germany

9.3.2    UK

9.3.3    France

9.3.4    Spain

9.3.5    Italy

9.3.6    Rest of Europe

9.4    Asia Pacific

9.4.1    China

9.4.2    Japan

9.4.3    India

9.4.4    Australia

9.4.5    Rest of Asia Pacific

9.5    Latin America

9.5.1    Brazil

9.5.2    Mexico

9.5.3    Rest of Latin America

9.6    Middle East and Africa

9.6.1    South Africa

9.6.2    Saudi Arabia

9.6.3    Rest of Middle East and Africa

Chapter 10   Company Profiles

10.1    Boehringer Ingelheim International GmbH

10.2    Bristol-Myers Squibb Company

10.3    Cipla Ltd.

10.4    GlaxoSmithKline plc

10.5    Glenmark Pharmaceuticals Ltd.

10.6    Merck & Co., Inc.

10.7    Sanofi

10.8    Takeda Pharmaceutical Company Limited.

10.9    Teva Pharmaceuticals Industries Ltd.

10.10    Zydus Group
 

Authors: Mariam Faizullabhoy, Gauri Wani

Buy Now


Premium Report Details

  • Base Year: 2023
  • Companies covered: 10
  • Tables & Figures: 237
  • Countries covered: 19
  • Pages: 132
 Download Free Sample